National Breast Implant Registry

Real World Data. Real World Impact.

	NBIR was developed in collaboration with the FDA, patients and breast implant manufacturers to strengthen post-market surveillance for breast implant devices.
	NBIR is the only clinical data registry named by the FDA in all breast implant device labeling and safety communications.
	NBIR supports validated device tracking with built-in Global Unique Device Identification Database (GUDID) technology.
	NBIR has 134,920 cases entered by 1,786 registered physicians as of March 1, 2025.

	Replace the Device Tracking Form, which will lead to less duplication of work.
	Satisfy your Practice Improvement Activity of Continuous Certification instead of your 10 tracer cases for the American Board of Plastic Surgery (ABPS).
	Collect accurate and meaningful data on your own practice, such as rates of reoperation, implant failure and your most common complications leading to reoperation.
	Contribute to patient safety for your own patients and for others across the country.
	Be recognized for your commitment with public-facing recognition on ASPS Find a Surgeon.

	NBIR is HIPAA-compliant and utilizes industry-wide privacy and security best practices to safeguard the confidentiality, integrity and availability of your data.
	Western Institutional Review Board has determined that the NBIR is not research and does not require IRB review. However, if your local IRB requires you to submit for further review, please contact research@plasticsurgery.org to obtain the necessary documents for your submission.